These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31632482)

  • 1. Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis.
    Song H; Wang T; Tian L; Bai S; Chen L; Zuo Y; Xue Y
    J Cancer; 2019; 10(22):5377-5387. PubMed ID: 31632482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer.
    Sakamoto S; Kagawa S; Kuwada K; Ito A; Kajioka H; Kakiuchi Y; Watanabe M; Kagawa T; Yoshida R; Kikuchi S; Kuroda S; Tazawa H; Fujiwara T
    Oncoimmunology; 2019; 8(12):e1671760. PubMed ID: 31741772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer.
    Chen X; Wang H; Huang Y; Chen Y; Chen C; Zhuo W; Teng L
    Front Oncol; 2021; 11():684871. PubMed ID: 34268118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF significance in peritoneal recurrence from gastric cancer.
    Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
    Gastric Cancer; 2005; 8(3):155-63. PubMed ID: 16086118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of peritoneal dissemination in gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2016 Aug; 22(30):6829-40. PubMed ID: 27570420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity.
    Miyamoto T; Murphy B; Zhang N
    Front Immunol; 2023; 14():1104694. PubMed ID: 37180125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
    Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
    J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody.
    Fushida S; Oyama K; Kinoshita J; Yagi Y; Okamoto K; Tajima H; Ninomiya I; Fujimura T; Ohta T
    Onco Targets Ther; 2013; 6():1445-51. PubMed ID: 24204159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the gastric cancer cell line MKN-45 and the high-potential peritoneal dissemination gastric cancer cell line MKN-45P.
    Koga A; Aoyagi K; Imaizumi T; Miyagi M; Shirouzu K
    Kurume Med J; 2011; 58(3):73-9. PubMed ID: 22531121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
    Kimura A; Ogata K; Altan B; Yokobori T; Mochiki E; Yanai M; Kogure N; Yanoma T; Suzuki M; Bai T; Kuwano H
    World J Gastroenterol; 2017 Nov; 23(42):7541-7550. PubMed ID: 29204054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peritoneal cavity is a distinct compartment of angiogenic molecular mediators.
    Nachtsheim R; Dudley B; McNeil PL; Howdieshell TR
    J Surg Res; 2006 Jul; 134(1):28-35. PubMed ID: 16650862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
    Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
    Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse forestomach carcinoma cells immunosuppress macrophages through TGF-β1.
    Luo H; Hao Y; Tang B; Zeng D; Shi Y; Yu P
    Turk J Gastroenterol; 2012; 23(6):658-65. PubMed ID: 23794301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
    Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
    Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury.
    Liu XY; Miao ZF; Zhao TT; Wang ZN; Xu YY; Gao J; Wu JH; You Y; Xu H; Xu HM
    Biochem Biophys Res Commun; 2013 Sep; 439(3):378-83. PubMed ID: 23994334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Development of Peritoneal Metastasis from Gastric Cancer and Rationale of Treatment According to the Mechanism.
    Yonemura Y; Ishibashi H; Mizumoto A; Tukiyama G; Liu Y; Wakama S; Sako S; Takao N; Kitai T; Katayama K; Kamada Y; Taniguchi K; Fujimoto D; Endou Y; Miura M
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.
    Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.